Deep Sequencing on HIV -1 Rebound viruses pol region under Long-acting ART and/or  CRISPR/Cas9 treatment
The goal is to investigate the dynamics and molecular signatures of the rebound variants, recovered from plasma under long-acting ART treatments (dolutegravir, lamivudine, abacavir, and rilpivirine combinations) and CRISPR-Cas9 targeting the HIV-1-LTR-gag.